Journal profile · Peripheral Vascular Disease
Journal of the Renin-Angiotensin-Aldosterone System
ISSN 1470-3203 · eISSN 1752-8976 · SAGE Publications Ltd · ENGLAND · Quarterly · Founded 2000
Journal of the Renin-Angiotensin-Aldosterone System: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 10.25; fully open access; APC about USD 4,150; review about 60 days (submission to acceptance, publisher); community-reported acceptance: fairly easy; 41 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of the Renin-Angiotensin-Aldosterone System is published by SAGE Publications Ltd and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Renin-Angiotensin System Studies, Hormonal Regulation and Hypertension and Blood Pressure and Hypertension Studies, together about 55.5% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Journal of the Renin-Angiotensin-Aldosterone System (JRAAS) is a peer-reviewed journal which focuses on the normal and abnormal function of the renin-angiotensin-aldosterone system and its pharmacology and therapeutics, mostly in a cardiovascular context but including research in all areas where this system is present, including the brain, lungs and gastro-intestinal … | View full journal description This journal is a member of the Committee on Publication Ethics (COPE).
From the journal's Aims & Scope
Research area (LetPub): Peripheral Vascular Disease
Editorial board by country: 15 in mainland China (about 41%); most named Mainland China 15, United States 10, United Kingdom 3, India 3, Iran 2 (37 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Renin-Angiotensin System StudiesMedicine29.9%
- Hormonal Regulation and HypertensionMedicine15%
- Blood Pressure and Hypertension StudiesMedicine10.6%
- Heart Failure Treatment and ManagementMedicine6.3%
- Chronic Kidney Disease and DiabetesMedicine4.2%
- Receptor Mechanisms and SignalingBiochemistry, Genetics and Molecular Biology4.1%
- Genetics and Physical PerformanceBiochemistry, Genetics and Molecular Biology3.5%
- Sodium Intake and HealthNursing2.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Peripheral Vascular Disease | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Peripheral Vascular Disease | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Peripheral Vascular Disease | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 10.25LetPub ·
- Impact factor (publisher)
- 10.6Publisher website ·
- 5-year impact factor (publisher)
- 4.3Publisher website ·
- CiteScore 2026-06
- 5.5LetPub ·
- SJR 2026-06
- 1.02LetPub ·
- SNIP 2026-06
- 1.23LetPub ·
- h-index
- 42LetPub ·
- h-index
- 59OpenAlex ·
- i10-index
- 717OpenAlex ·
- 2-year mean citedness
- 1.83OpenAlex ·
- Self-citation rate
- 7.5%LetPub ·
- Share of gold OA articles
- 46.15%LetPub ·
Volume
- Articles per year
- 32LetPub ·
- Articles per year (publisher)
- 3Publisher website ·
Articles by year OpenAlex count · 1,323 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 38 | 6 | 11 |
| 2025 | 41 | 5 | 89 |
| 2024 | 7 | 7 | 57 |
| 2023 | 14 | 14 | 328 |
| 2022 | 20 | 19 | 391 |
| 2021 | 25 | 25 | 342 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Publisher-reported review time from the journal's website
60 dayssubmission to acceptance · community reports 6–12 weeks
The publisher's own definition applies; dates from this journal's articles in the last 24 months are not available yet, so the publisher's figure is used.
Figures by source
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Acceptance rate (publisher)
- 37.1%Publisher website ·
- Submission to first decision
- 2 daysPublisher website ·
- First decision after review
- 20 daysPublisher website ·
- Submission to acceptance
- 60 daysPublisher website ·
- Acceptance to publication
- 23 daysPublisher website ·
- Peer review
- Anonymous peer reviewLetPub
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessLetPub
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,150 / GBP 3,043 | — | — | |
| LetPub | USD 2,175 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Manuscript length
- ≤ 5,000 words
- Reference style
- Vancouver
- First submission
- Free format: the journal's layout is not required
Article types accepted11, with length limits
- case reportPlease visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstracts. Manuscripts are considered for publication with the unders…main text ≤ 2,500 words
- hypothesisPlease visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstracts. Manuscripts are considered for publication with the unders…Length not stated
- letterPlease visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstracts. Manuscripts are considered for publication with the unders…Length not stated
- lettersLetters: are encouraged to provide comments on previously published papers or on important or novel aspects of research in the field.Length not stated
- original articlePlease visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstracts. Manuscripts are considered for publication with the unders…main text ≤ 5,000 words
- original articlesOriginal Articles: may appear as full length reports (approximately 5,000 words excluding references and figure legends) or short communication (approximately 1…Length not stated
- reviewPlease visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstracts. Manuscripts are considered for publication with the unders…Length not stated
- review articlePlease visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstracts. Manuscripts are considered for publication with the unders…Length not stated
- review articlesReview Articles: provide in-depth surveys of recent advances in a field.Length not stated
- short communicationPlease visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstracts. Manuscripts are considered for publication with the unders…main text ≤ 1,500 words
- surveyPlease visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstracts. Manuscripts are considered for publication with the unders…Length not stated
Policy excerpts from the journal's websiteAuthorship, Data availability, Publication ethics, Open access, Peer review, Plagiarism, Preprints, Trial registration / reporting guidelines
- Authorship Authorship
Please view our authorship policies, which includes information on criteria for authorship, who should be the corresponding author and more. Please note that AI chatbots, for example ChatGPT, should not be listed as authors. For more information see the policy on Use of ChatGPT and generative AI tools.
Source ↗Publisher website ·- Data availability Data availability
The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. Subject to appropriate ethical and legal considerations, authors are encouraged to: Share your research data in a relevant public data repository Include a data ava…
Source ↗Publisher website ·- Publication ethics Ethical considerations
Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…
Source ↗Publisher website ·- Open access Publishing fees and open access
Online only Model summary
There are no fees payable to submit or publish in this journal. Optional open access publishing is available for a fee via the Sage Choice program, and Open Access agreements, where authors can publish open access either discounted or free of charge depending on the agreement with Sage. Find out if your institution is participating by visiting Open Access Agreements at Sage. Open Access agreement …
Source ↗Publisher website ·- Peer review Peer review policy
Single anonymized review Model summary
The following summary describes the peer review process for this journal: Identity transparency: Single-anonymized Reviewer interacts with: Editor Review information published: None Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscripts may be desk rejec…
Source ↗Publisher website ·- Plagiarism Plagiarism
The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.
Source ↗Publisher website ·- Preprints Preprints
The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical trial registration
The journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- SAGE Publications Ltd
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Quarterly
- Founded
- 2000
- ISSN
- 1470-3203
- Electronic ISSN
- 1752-8976
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Journal of the Renin-Angiotensin-Aldosterone System
What CAS zone is Journal of the Renin-Angiotensin-Aldosterone System in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of the Renin-Angiotensin-Aldosterone System is in Zone 4 of Medicine, and in Zone 4 of the minor category Peripheral Vascular Disease. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of the Renin-Angiotensin-Aldosterone System?
The latest impact factor listed by LetPub is 10.25; CiteScore 5.5, h-index 59.
How long does peer review take at Journal of the Renin-Angiotensin-Aldosterone System?
The publisher reports about 60 days (submission to acceptance); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Fairly easy”; the journal's website gives an acceptance rate of 37.1%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of the Renin-Angiotensin-Aldosterone System?
According to the journal's author guidelines: Manuscript length: ≤ 5,000 words; Reference style: Vancouver; First submission: Free format: the journal's layout is not required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of the Renin-Angiotensin-Aldosterone System based?
Of the 37 board members whose country the journal's board page names, 15 (about 41%) are in mainland China; the countries named most often are Mainland China (15), United States (10) and United Kingdom (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of the Renin-Angiotensin-Aldosterone System?
According to LetPub and DOAJ records, Journal of the Renin-Angiotensin-Aldosterone System is indexed in SCIE and Scopus.
Is Journal of the Renin-Angiotensin-Aldosterone System open access, and what is the APC?
Journal of the Renin-Angiotensin-Aldosterone System is a fully open-access journal. APC about USD 4,150.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .